Skip to main content

Funding Opportunities and Announcements

Limited Interaction Targeted Epidemiology (LITE-2): To Advance HIV Prevention (UG3/UH3 Clinical Trial Optional)

Limited Competition: Development and Renovation of Research Space for HIV/AIDS Research at Institutions Serving Underrepresented Populations or Located in Institutional Development Award (IDeA)-eligible States (C06 Clinical Trial Not Allowed)

Notice of Special Interest (NOSI): Multi-Level HIV Prevention Interventions for Individuals at the Highest Risk of HIV Infection

Notice of Special Interest (NOSI): Administrative Supplements to NIMHD Awards for Research on HIV/AIDS in Populations that Experience Health Disparities (Admin Supp Clinical Trial Optional)

NIMH Research Education Mentoring Program for HIV/AIDS Researchers (R25 Clinical Trial Not Allowed)

PrEP for HIV Prevention among Substance Using Populations (R01 - Clinical Trial Optional)

National HIV Behavioral Surveillance (NHBS) grant from Centers for Disease Control - NCHHSTP

Innovative Models for Delivering PrEP and STI Services to Stop HIV in the United States (R61/R33 Clinical Trial Optional)

Short-Term Research Education Program to Enhance Diversity in Health-Related Research (R25 Clinical Trial Not Allowed)

Engaging Men in HIV Testing, Prevention, and Care (R01 Clinical Trial Optional), Department of Health and Human Services, National Institutes of Health

Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 Clinical Trial Optional)

Prevention Strategies to End the HIV Epidemic (R01 Clinical Trial Optional)

Respond: Epidemiology to End the HIV Epidemic (RESPOND: EEE) (R01 Clinical Trial Optional)

Multidisciplinary Treatment Approaches to End the HIV Epidemic (R01 Clinical Trial Optional)

Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R61/R33 - Clinical Trial Not Allowed).

New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial Required)

Four New Funding Opportunities, Rapid Acceleration of Diagnostics (RADX) Related to COVID-19 Testing

Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional)  

Advancing HIV/AIDS Research within the Mission of the NIDCD (two opportunities), standard AIDS dates apply. Expires in 2023:

NIDA Avant-Garde Award Program for HIV/AIDS and Substance Use Disorder Research (DP1, Clinical Trial Optional)

Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18 No Independent Clinical Trials)

Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed)